Acute myocardial infarction in elderly patients

##plugins.themes.academic_pro.article.main##

Nadhem Hajlaoui
Hedi Ellefi
Badii Jdaida
Abdeddayem Haggui
Thouraya FILALI
Mehdi Ghommidh
Imène Saaidi
Dhaker Lahidheb
Wafa Fehri
Habib Haouala

Abstract

Background: Age is the most important determinant of outcome for patients with acute coronary syndromes (ACS) and ischemic heart disease is the leading cause of death among elderly patients.
Aim: To determine the epidemiologic particularities, the clinical presentation, and the treatment of Acute Myocardial Infarction (AMI) in patients over 65 years.
Methods: One hundred patients >65 years of age with myocardial infarction were hospitalized in intensive care of cardiologic unit of Military Hospital of Tunis between 2000 and 2008. Clinical characteristics, reperfusion therapy and outcomes of in-hospital period and for one year follow-up were seen for every patient.
Results: The mean age of our population was 77 years. Sex-ratio was 3/1.Our population was divided into tow groups; patients aged between 65 and 75 years (48 patients) and those aged more than 75 years (52 patients). Only 44 % of our patients had arrived at the hospital within the first 12 hours. STEMI was found in 65 % of our patients. At admission, 40 % had congestive heart failure (³ Killip II), 10 % were in cardiogenic shock. Urgent reperfusion therapy was given to 58 % of our patients; 33% received a thrombolytic therapy and 25 % were allocated to primary PCI. During in-hospital period, 40 % have developed congestive heart failure, 20 % have had a cardiogenic shock and 12 % were died. All these events were more frequent in patients aged over 75 years and reperfusion therapy was associated with best outcome.
Conclusion: In our study invasive treatment such as fibrinolysis and PCI was associated to better outcome in acute period and at 12 months of follow up in elderly patients treated for AMI.

Keywords:

Myocardial infarction, acute coronary syndrome, elderly, reperfusion

##plugins.themes.academic_pro.article.details##

References

  1. Mackay J, Mensah G, et al. The future of CVD. The Atlas of Heart Disease and Stroke. World Health Organization; 2004; 10: 74-75.
  2. Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease specific guidelines for patients with multiple conditions. N Engl J Med. 2004; 351:2870-74.
  3. H. Benamer, J. Lefèvre, A. Debure, et al. Coronary artery disease and coronary angioplasty n chronic hemodialysis patients. Ann Cardiol Angéiol 2007; 56:10-5.
  4. Lindner A, Charra B, Sherrard DJ, et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290:697-701.
  5. Yarzebski J, Goldberg RJ, Gore JM, et al. Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J 1994; 128:255-63.
  6. Gurwitz JH, McLaughlin TJ, Willison DJ, et al. Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med. 1997; 126:593-9.
  7. S E. Sheifer, SS. Rathore, BJ. Gersh et al. Time to Presentation With Acute Myocardial Infarction in the Elderly: Associations With Race, Sex, and Socioeconomic Characteristics. Circulation 2000; 102:1651-6.
  8. Friocourt P, Lemarcis L, Poitruneau, et al. Myocardial infarction in the aged patient. La Revue de Gériatrie 2002; 27:4-8.
  9. Jaqemain L, Danchin N, Suty-Selon C, et al. L'infarctus du myocarde chez le sujet âgé de plus de 75 ans ou plus. Presse Med 1996; 25:536-40.
  10. Karen P, Alexander L, Kristin Newby et al. Acute Coronary Care in the Elderly, Part I: Non-ST-Segment-Elevation Acute Coronary Syndromes. Circulation 2007; 115:2549-69.
  11. Yarzebski J, Goldberg RJ, Gore JM, et al. Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J 1994; 128:255-63.
  12. Mehta RH, Granger CB, Alexander KP, et al. Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks. J Am Coll Cardiol 2005; 45:471-8.
  13. Gurwitz JH, McLaughlin TJ, Willison DJ, et al. Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med. 1997; 126:593-9.
  14. SE. Sheifer, SS. Rathore, BJ. Gersh et al. Time to Presentation With Acute Myocardial Infarction in the Elderly : Associations With Race, Sex, and Socioeconomic Characteristics. Circulation 2000; 102:1651-6.
  15. Friocourt P, Lemarcis L, Poitruneau, et al. Myocardial infarction in the aged patient. La Revue de Gériatrie 2002; 27:4-8.
  16. Mehta RH, Rathore SS, Radford MJ, Wang Y, Wang Y, Krumholz HM. Acute myocardial infarction in the elderly: differences by age.J Am Coll Cardiol. 2001; 38:736-41.
  17. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343:311-22.
  18. Lesnefsky EJ, Lundergan CF, Hodgson JM et al. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-1 angiographic experience. J Am Coll Cardiol 1996; 28:331-7.
  19. Stenestrand U, Wallentin L. Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Fibrinolytic therapy in patients 75 years and older with ST-segment elevation myocardial infarction: one-year follow-up for large prospective cohort. Arch Intern Med 2003; 163:965-71.
  20. Dove JT, Jacobs AK, Kennedy JW, et al. ACC/AHA guidelines for percutaneous coronary intervention. J Am Coll Cardiol 2001; 37:2215-38.
  21. Grines CL, Browne KF, Marco J, et al. the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328:673-9.
  22. Andersen HR, Nielsen TT, Rasmussen K, et al. DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349:733-42.
  23. Thune JJ, Hoefsten DE, Lindholm MG, et al. Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI)-2 Investigators. Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty. Circulation 2005; 112:2017-21.
  24. Steg PG, Bonnefoy E, Chabaud S, et al. Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003; 108:2851-6.
  25. Schomig A, Mehilli J, Antoniucci D, et al. Beyond 12 Hours Reperfusion AlternatiVe Evaluation (BRAVE-2) Trial Investigators. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA. 2005;293:2865-72.
  26. Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction— etiologies, management and outcome: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries for cardiogenic shock ? J Am Coll Cardiol 2000; 36:1063-70.